The Onset of Inhibition of Platelet Aggregation With Prasugrel Compared With Clopidogrel Loading Doses Using Gatekeeping Analysis of Integrated Clinical Pharmacology Data
Baojin Zhu(Eli Lilly (United States)), Kenneth J. Winters(Eli Lilly (United States)), Mark B. Effron(Eli Lilly (United States)), Brian Baker, Pandurang M. Kulkarni(Solapur University), Joseph A. Jakubowski(Indiana Biosciences Research Institute), David S. Small(Eli Lilly (United States)), Ying G. Li(Eli Lilly (United States)), Junxiang Luo(Eli Lilly (United States)), Debra L. Miller(University of Nottingham)
Cited by 20
Related Papers
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention
|Circulation|2007|882
Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
|New England Journal of Medicine|2013|651
A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents
|Journal of the American College of Cardiology|2012|617